6-hexadecanoylamino-4-methylumbelliferyl-galactopyranoside has been researched along with taurocholic acid in 1 studies
| Studies (6-hexadecanoylamino-4-methylumbelliferyl-galactopyranoside) | Trials (6-hexadecanoylamino-4-methylumbelliferyl-galactopyranoside) | Recent Studies (post-2010) (6-hexadecanoylamino-4-methylumbelliferyl-galactopyranoside) | Studies (taurocholic acid) | Trials (taurocholic acid) | Recent Studies (post-2010) (taurocholic acid) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 3,789 | 26 | 654 |
| Protein | Taxonomy | 6-hexadecanoylamino-4-methylumbelliferyl-galactopyranoside (IC50) | taurocholic acid (IC50) |
|---|---|---|---|
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 6 | |
| Sodium/bile acid cotransporter | Rattus norvegicus (Norway rat) | 6 | |
| Sodium/bile acid cotransporter | Homo sapiens (human) | 5.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kolodny, E; Raghavan, S; Wiederschain, G | 1 |
1 other study(ies) available for 6-hexadecanoylamino-4-methylumbelliferyl-galactopyranoside and taurocholic acid
| Article | Year |
|---|---|
Characterization of 6-hexadecanoylamino-4-methylumbelliferyl-beta-D- galactopyranoside as fluorogenic substrate of galactocerebrosidase for the diagnosis of Krabbe disease.
Topics: Animals; Brain; Carbohydrate Sequence; Cells, Cultured; Clinical Enzyme Tests; Dose-Response Relationship, Drug; Female; Fibroblasts; Fluorescent Dyes; Galactosides; Galactosylceramidase; Galactosylceramides; Humans; Hydrolysis; Hymecromone; Leukocytes; Leukodystrophy, Globoid Cell; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Oleic Acid; Oleic Acids; Substrate Specificity; Taurocholic Acid | 1992 |